9-99828856-G-C

Variant summary

Our verdict is Uncertain significance. The variant received 1 ACMG points: 2P and 1B. PM2BP4

The NM_006981.4(NR4A3):​c.814G>C​(p.Gly272Arg) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)

Consequence

NR4A3
NM_006981.4 missense

Scores

2
8
9

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 5.38

Publications

0 publications found
Variant links:
Genes affected
NR4A3 (HGNC:7982): (nuclear receptor subfamily 4 group A member 3) This gene encodes a member of the steroid-thyroid hormone-retinoid receptor superfamily. The encoded protein may act as a transcriptional activator. The protein can efficiently bind the NGFI-B Response Element (NBRE). Three different versions of extraskeletal myxoid chondrosarcomas (EMCs) are the result of reciprocal translocations between this gene and other genes. The translocation breakpoints are associated with Nuclear Receptor Subfamily 4, Group A, Member 3 (on chromosome 9) and either Ewing Sarcome Breakpoint Region 1 (on chromosome 22), RNA Polymerase II, TATA Box-Binding Protein-Associated Factor, 68-KD (on chromosome 17), or Transcription factor 12 (on chromosome 15). Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2010]
NAMA (HGNC:42408): (non-protein coding RNA, associated with MAP kinase pathway and growth arrest)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 1 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.3647893).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NR4A3NM_006981.4 linkc.814G>C p.Gly272Arg missense_variant Exon 3 of 8 ENST00000395097.7 NP_008912.2 Q92570-1A0A024R168
NR4A3NM_173200.3 linkc.847G>C p.Gly283Arg missense_variant Exon 4 of 9 NP_775292.1 Q92570-3
NR4A3NM_173199.4 linkc.814G>C p.Gly272Arg missense_variant Exon 3 of 5 NP_775291.1 Q92570-2
NR4A3XM_017015162.2 linkc.814G>C p.Gly272Arg missense_variant Exon 4 of 9 XP_016870651.1 Q92570-1A0A024R168

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NR4A3ENST00000395097.7 linkc.814G>C p.Gly272Arg missense_variant Exon 3 of 8 1 NM_006981.4 ENSP00000378531.2 Q92570-1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
33
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Mar 27, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.847G>C (p.G283R) alteration is located in exon 4 (coding exon 2) of the NR4A3 gene. This alteration results from a G to C substitution at nucleotide position 847, causing the glycine (G) at amino acid position 283 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.48
BayesDel_addAF
Uncertain
0.091
D
BayesDel_noAF
Benign
-0.11
CADD
Benign
19
DANN
Uncertain
1.0
DEOGEN2
Benign
0.36
.;T;.;.
Eigen
Uncertain
0.39
Eigen_PC
Uncertain
0.41
FATHMM_MKL
Pathogenic
0.97
D
LIST_S2
Benign
0.74
T;T;T;.
M_CAP
Pathogenic
0.33
D
MetaRNN
Benign
0.36
T;T;T;T
MetaSVM
Uncertain
0.47
D
MutationAssessor
Benign
0.69
N;N;.;.
PhyloP100
5.4
PrimateAI
Uncertain
0.76
T
PROVEAN
Benign
-1.3
N;N;.;N
REVEL
Uncertain
0.37
Sift
Benign
0.41
T;T;.;T
Sift4G
Benign
0.14
T;T;T;T
Polyphen
0.96
D;P;P;P
Vest4
0.47
MutPred
0.16
Loss of glycosylation at S269 (P = 0.0672);Loss of glycosylation at S269 (P = 0.0672);.;.;
MVP
0.92
ClinPred
0.79
D
GERP RS
4.9
Varity_R
0.25
gMVP
0.35
Mutation Taster
=47/53
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

hg19: chr9-102591138; API